|
|
||||||||||||||||||||||||||||||||||||||
By The Online Investor Staff, updated Tue., Jul. 7, 1:50 AM
|
|||||||||||||||||||||||||||||||||||||||
Secondary Stock Offerings| This Slide: #1 of 25 |
Slide #1. Ascendis Pharma A/S — Secondary Offering
Company:
Ascendis Pharma A/S (NASDAQ:ASND)
Date announced:
7/6/2020
Secondary Offering Details:
Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to address unmet medical needs, today announced that it has commenced an underwritten public offering of $500,000,000 of American Depositary Shares ("ADSs"), each of which represents one ordinary share of Ascendis. All of the ADSs are being offered by Ascendis. In addition, Ascendis expects to grant the underwriters a 30-day option to purchase up to an additional $75,000,000 of ADSs at the public offering price, less the underwriting commissions. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
Ascendis Pharma is a biopharmaceutical company. Co.'s key product candidate, TransCon hGH, is in development as a once-weekly long acting prodrug of recombinant human growth hormone, also referred to as hGH, as a potential treatment for growth hormone deficiency. Co. is also using its TransCon technology platform to develop TransCon PTH, a once-daily long-acting prodrug of parathyroid hormone, or PTH, as a potential treatment for hypoparathyroidism, a rare endocrine disorder of calcium and phosphate metabolism. Co. is also developing TransCon CNP, a long-acting prodrug of C-type natriuretic peptide, as a potential therapeutic option for achondroplasia, the most common form of dwarfism.
Open the ASND Page at The Online Investor »
|
|||||||||||||||
Open the ASND Page at The Online Investor (in a new window) »
|
6/22/2020:
Company: Celsion Corporation (CLSN)
Shares Offered: 2,666,667
More: offering details »
6/23/2020:
Company: Soleno Therapeutics, Inc. (SLNO)
Shares Offered: 30,303,030
More: offering details »
6/23/2020:
Company: Palomar Holdings, Inc. (PLMR)
Shares Offered: 1,000,000
More: offering details »
6/23/2020:
Company: TELA Bio, Inc. (TELA)
Shares Offered: 3,000,000
More: offering details »
6/23/2020:
Company: Editas Medicine, Inc. (EDIT)
Shares Offered: 6,000,000
More: offering details »
6/23/2020:
Company: Avinger, Inc. (AVGR)
More: offering details »
6/24/2020:
Company: Evelo Biosciences, Inc. (EVLO)
Shares Offered: 12,000,000
More: offering details »
6/24/2020:
Company: Translate Bio, Inc. (TBIO)
Shares Offered: 12,506,811
More: offering details »
6/24/2020:
Company: Yandex N.V. (YNDX)
Shares Offered: 8,121,827
More: offering details »
6/24/2020:
Company: 1Life Healthcare, Inc. (ONEM)
Shares Offered: 8,300,000
More: offering details »
6/25/2020:
Company: Franchise Group, Inc. (FRG)
Shares Offered: 4,200,000
More: offering details »
6/26/2020:
Company: Soliton, Inc. (SOLY)
Shares Offered: 4,216,868
More: offering details »
6/29/2020:
Company: CRISPR Therapeutics (CRSP)
Shares Offered: 6,428,572
More: offering details »
6/29/2020:
Company: Liquidia Technologies, Inc. (LQDA)
Shares Offered: 9,375,000
More: offering details »
6/29/2020:
Company: XP Inc. (XP)
Shares Offered: 19,535,420
More: offering details »
6/29/2020:
Company: II-VI Incorporated (IIVI)
Shares Offered: 9,302,235
More: offering details »
6/29/2020:
Company: II-VI Incorporated (IIVI)
Shares Offered: 2,000,000
More: offering details »
7/1/2020:
Company: BioLife Solutions, Inc. (BLFS)
Shares Offered: 5,175,000
More: offering details »
7/1/2020:
Company: Neoleukin Therapeutics, Inc. (NLTX)
Shares Offered: 3,262,471
More: offering details »
7/1/2020:
Company: Envision Solar International, Inc. (EVSI)
Shares Offered: 1,212,121
More: offering details »
7/1/2020:
Company: Document Security Systems, Inc. (DSS)
Shares Offered: 1,028,800
More: offering details »
7/6/2020:
Company: 89bio, Inc. (ENTB)
Shares Offered: 2,200,000
More: offering details »
7/6/2020:
Company: Akero Therapeutics, Inc. (AKRO)
Shares Offered: 4,750,000
More: offering details »
7/6/2020:
Company: Vir Biotechnology, Inc. (VIR)
Shares Offered: 6,200,000
More: offering details »
7/6/2020:
Company: Ascendis Pharma A/S (ASND)
More: offering details »
|
|
Avg. Broker Rec.
 
|
Strong Buy (3.93 out of 4) 79th percentile
(ranked higher than approx. 79% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |
Secondary Stock Offerings | www.TheOnlineInvestor.com | Copyright © 1998 - 2020, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.